Precision Nutrition Market

Market Definition

Precision nutrition is a personalized approach to nutrition that considers an individual’s genetic makeup, microbiome, metabolism, lifestyle, and environmental factors to create tailored dietary recommendations. Precision nutrition aims to optimize health outcomes by using data-driven insights, such as biomarkers, DNA analysis, and real-time monitoring of an individual’s response to foods.

Precision Nutrition Market Overview

The global precision nutrition market size was valued at USD 6.23 billion in 2023 and is projected to grow from USD 7.20 billion in 2024 to USD 20.96 billion by 2031, exhibiting a CAGR of 16.49% during the forecast period. This market is experiencing rapid growth, driven by advancements in biotechnology, personalized healthcare, and increasing consumer demand for tailored dietary solutions.

The integration of AI, big data, and genetic testing in neutrition analysis has enabled more accurate and individualized nutrition recommendations, fueling the adoption of precision nutrition across healthcare, fitness, and wellness industries.

Moreover, growing awareness of chronic diseases is further accelerating market expansion, as consumers seek personalized solutions for weight management, metabolic health, and overall well-being.

Major companies operating in the global precision nutrition industry are Viome Life Sciences, Inc., ZOE Limited, Prenetics Global Limited, SelfDecode, 23andMe, Inc., GENESIS HEALTH AND LIFESTYLE SOLUTIONS, AMILI Pte. Ltd., HealthifyMe Wellness Private Limited, Segterra, Inc., Nutrigenomix, Wednesday Health India Pvt. Ltd., Biospan Limited & Biospan LLC, Vitaminpacks, Inc., and NAHIBU.

The rising popularity of wearable devices and digital health platforms has also contributed to the market’s expansion, allowing real-time tracking of nutritional intake and metabolic responses.

Additionally, the expansion of nutrigenomics research and the increasing availability of direct-to-consumer genetic testing kits are allowing individuals to make informed dietary choices based on their individual biology. As the focus on preventive healthcare and personalized wellness continues to rise, the market is expected to witness sustained growth.

Key Highlights:                     

1. The global precision nutrition market size was valued at USD 6.23 billion in 2023.
2. The market is projected to grow at a CAGR of 16.49% from 2024 to 2031.
3. North America held a market share of 33.78% in 2023, with a valuation of USD 2.10 billion.
4. The genomics segment garnered USD 1.99 billion in revenue in 2023.
5. The general health & wellness segment is expected to reach USD 8.08 billion by 2031.
6. The residential segment is expected to reach USD 8.97 billion by 2031.
7. The market in Asia Pacific is anticipated to grow at a CAGR of 17.50% during the forecast period.

Market Driver

"Rising Prevalence of Chronic Diseases and Advancements in Genomics are Fueling the Growth of the Market"

The precision nutrition market is experiencing significant growth, driven by the rising prevalence of chronic diseases and advancements in genomics and AI. With increasing cases of obesity, diabetes, cardiovascular diseases, and autoimmune disorders, there is a growing demand for personalized dietary solutions that cater to individual genetic and metabolic needs.

Consumers and healthcare providers are seeking data-driven nutrition plans to manage and prevent diet-related conditions. Additionally, rapid advancements in genetic testing, microbiome analysis, and AI-driven insights in nutritional science are revolutionizing precision nutrition, enhancing personalization through data-driven dietary recommendations.

AI algorithms are able to analyze millions of genetic data points to provide tailored dietary recommendations.

• In January 2025, Eurecat announced its advancement in precision nutrition using single-cell genomics technology. The technology will assess the health impact of alternative protein diets and characterize cultured meat cells, contributing to food sustainability and personalized nutrition.

Market Challenge

"Cost Barriers and Data Privacy Concerns in the Precision Nutrition Market"

The market faces several challenges that hinder widespread adoption. This includes high cost associated with genetic testing and concerns over data privacy and security. Precision nutrition relies on advanced technologies such as whole-genome sequencing, microbiome analysis, and AI-driven data interpretation.

These processes require significant investment in research, laboratory infrastructure, and skilled professionals, making the services expensive and inaccessible for many consumers.

As a result, personalized nutrition is regarded as a premium service rather than a mainstream healthcare solution. However, ongoing advancements in biotechnology, increased competition among genetic testing companies, and cost efficiencies achieved through large-scale production are gradually reducing costs.

Furthermore, the risk of data breaches, unauthorized access, and misuse of genetic information is making consumers reluctance to adopt personalized nutrition solutions. To address this issue, companies must implement robust cybersecurity measures, encryption protocols, and strict adherence to global data protection regulations.

Market Trend

"Microbiome-Based Nutrition and Digital Health Platforms"

The precision nutrition market is evolving rapidly, driven by the increasing popularity of microbiome-based nutrition and the rising demand for nutrigenomics-based dietary solutions. As research continues to reveal the critical role of gut health in overall well-being, microbiome-based nutrition is gaining traction.

Companies are leveraging gut microbiome sequencing and probiotics-based interventions to create highly individualized diet plans that optimize digestion, immunity, and metabolic health. Additionally, the growing integration of functional foods and nutraceuticals into precision nutrition strategies is emerging as a key trend.

These products are designed to provide targeted health benefits, such as improved heart health, enhanced cognitive function, and better weight management, aligning with personalized dietary needs. Together, these trends are shaping the future of the market, making personalized dietary solutions more advanced and widely available.

• In February 2024, Hologram Sciences collaborated with Mayo Clinic to develop the precision nutrition platform to address malnutrition challenges in surgical recovery and enhance patient care. The platform will leverage advanced machine learning and predictive analytics integrating Mayo Clinic’s clinical protocols to provide personalized nutrition solutions.

Precision Nutrition Market Report Snapshot

Segmentation	Details
By Technology	Metabolomics, Genomics, Transcriptomics, Proteomics
By Application	Disease Management, General Health & Wellness, Weight Management
By End-User	Residential, Commercial, Industrial
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation:

• By Technology (Metabolomics, Genomics, Transcriptomics, Proteomics): The genomics segment earned USD 1.99 billion in 2023 due to the increasing adoption of genetic testing for personalized dietary recommendations.
• By Application (Disease Management, General Health & Wellness, Weight Management): The general health & wellness segment held 38.46% of the market in 2023, due to the rising consumer preference for preventive healthcare and customized nutrition plans.
• By End-User (Residential, Commercial, Industrial): The residential segment is projected to reach USD 8.07 billion by 2031, owing to the growing demand for home based nutrition solutions and digital health integration.

Precision Nutrition Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

North America accounted for a substantial precision nutrition market share of 33.78% in 2023 in the global market, with a valuation of USD 2.10 billion. This growth is fueled by a well-established healthcare system, strong government funding, and the presence of major pharmaceutical and biotechnology companies that offer advance precision nutrition.

Additionally, favorable regulatory frameworks and fast-track approval processes for precision medicine therapies further support market growth. The region also benefits from advanced research infrastructure, with institutions and universities driving innovation through extensive clinical trials and genomic studies.

Partnerships between academic institutions, medical facilities, and pharmaceutical firms are enabling innovation in big data analytics, AI, and ML to improve individualized treatment strategies.

• In July 2024, the United States Department of Agriculture (USDA) invested USD 4.5 millon to establish three new Nutrition Hubs aimed at improving food and nutrition security and preventing diet-related diseases in underserved communities. These hubs, part of the ASCEND for Better Health initiative, will utilize precision nutrition research to provide personalized dietary guidance.

The precision nutrition industry in Asia Pacific is expected to register fastest growth in the market, with a projected CAGR of 17.50% over the forecast period. This rapid expansion is driven by rising investments in biotechnology and increasing government support.

Moreover, growing adoption of genomic sequencing in countries such as China, Japan, and India is further driving the growth of the market. Rising incidences of chronic diseases such as cancer and cardiovascular conditions, are also increasing the demand for tailored therapies across the region.

Additionally, advancements in next-generation sequencing (NGS) and digital health solutions are accelerating the adoption of precision medicine. NGS technology enables rapid and cost-effective genome sequencing, allowing healthcare providers to analyze genetic variations, biomarkers, and mutations with greater accuracy.

This comprehensive genetic profiling enhances the identification of disease risks, treatment responses, and individualized therapeutic strategies, making precision medicine more effective and accessible in the Asia-Pacific region.

Regulatory Frameworks

• In the U.S., the Food and Drug Administration (FDA) regulates the safety, efficacy, and labeling of dietary supplements, functional foods, and nutrigenomics-based products to ensure consumer protection.
• In Europe, the European Food Safety Authority (EFSA) is responsible for evaluating and approving health claims for functional foods and nutrigenomic products to ensure scientific validity. Furthermore, companies operating in the precision nutrition sector must comply with the General Data Protection Regulation (GDPR) to protect personal genetic and health data from unauthorized access and misuse.
• In China, the National Medical Products Administration (NMPA) oversees the approval and regulation of personalized nutrition products, including dietary supplements and functional foods, ensuring they meet safety and efficacy standards. The National Health Commission (NHC) provides guidelines for integrating AI and genomics into healthcare and nutrition-based applications, ensuring ethical and responsible implementation.
• In Japan, the Ministry of Health, Labour and Welfare (MHLW) regulates functional foods under the Food with Health Claims (FHC) system, requiring scientific validation before approving nutrition-related claims.
• In India, the Food Safety and Standards Authority of India (FSSAI) governs the safety, labeling, and health claims of functional foods and nutrigenomics-based dietary products to ensure consumer trust and regulatory compliance. The Indian Council of Medical Research (ICMR) provides guidelines for the ethical use of genetic and metabolic data in personalized nutrition solutions, promoting responsible research and application.

Competitive Landscape

The global precision nutrition market is characterized by a large number of participants. The market is driven by continuous advancements in nutrigenomics, AI-based dietary recommendations, and personalized wellness solutions. Companies are focusing on expanding their product portfolios by integrating DNA testing, microbiome analysis, and metabolic profiling to offer customized nutrition plans.

Additionally, the industry is witnessing a surge in strategic partnerships, mergers, and acquisitions as companies seek to enhance their technological capabilities and expand their global footprint.

Many firms are investing in direct-to-consumer (DTC) platforms, enabling individuals to access personalized nutrition insights through digital health apps and wearable technology. Innovation remains a key differentiator, with organizations emphasizing scientific research, clinical validation, and AI-driven data analytics to refine precision nutrition solutions.

• In November 2024, Prenetics and David Beckham launched IM8 Health, a wellness brand offering Daily Ultimate Essentials and Daily Ultimate Longevity supplements. These products are formulated to support overall health, energy levels, and longevity through a blend of essential vitamins, minerals, and antioxidants, catering to individuals seeking comprehensive daily nutrition. The launch follows Prenetics' acquisition of Europa Sports Partners, expanding into the global health market.

List of Key Companies in Precision Nutrition Market:

• Viome Life Sciences, Inc.
• ZOE Limited
• Prenetics Global Limited
• SelfDecode
• 23andMe, Inc.
• GENESIS HEALTH AND LIFESTYLE SOLUTIONS
• AMILI Pte. Ltd.
• HealthifyMe Wellness Private Limited
• Segterra, Inc.
• Nutrigenomix
• Wednesday Health India Pvt. Ltd.
• Biospan Limited & Biospan LLC
• Vitaminpacks, Inc.
• NAHIBU

Recent Developments (Partnerships)

• In February 2025, Samsung Nordic announced an exclusive partnership with Revive, a health tech company, to offer users a precision nutrition solution powered by AI-driven genetic insights. The collaboration integrates Revive’s genetic-based nutrition program into Samsung’s health ecosystem to deliver personalized dietary recommendations. These are based on advanced biochemistry and AI analysis of 200 million genome data points.
• In March 2024, the American Council on Exercise (ACE) expanded its partnership with Precision Nutrition to launch the AI Bootcamp for Coaches, an on-demand course designed to help health and exercise professionals integrate AI tools into their practice. This initiative aligns with the increasing role of AI in fitness and wellness.